華神科技(000790.SZ):擬參與設立醫美醫院公司
格隆匯6月8日丨華神科技(000790.SZ)公佈,為加快推進醫美大健康業務戰略實施,公司(或公司指定的下屬控股子公司)與四川成都中醫大資產管理有限公司(簡稱"中醫大資管")、成都美源創美醫療管理合夥企業(有限合夥)(簡稱"美源創美")及成都新谷華創科技有限公司(簡稱"新谷華創")擬簽署《投資協議》,共同出資人民幣8,000萬元在成都市高新區設立成都中醫大華神醫美醫院有限公司(暫定名,最終以工商註冊登記為準,簡稱"醫美醫院公司"),並以此為載體,開辦醫療美容業務,並積極佈局醫美生態鏈產品的研發、生產和銷售等相關產業,構建集醫美醫院、醫美學院、醫美產品研究院"醫、教、研三院一體"的業務發展模式。具
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.